Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of a vaccine therapy for stage III or stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Melanoma (Skin) | Phase 2 | Status: UNKNOWN